Monoclonal Antibodies as Drugs or Devices: Practicaland Regulatory Aspects
- 1 January 1986
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 12 (1-2) , 107-227
- https://doi.org/10.3109/03639048609048022
Abstract
(1986). Monoclonal Antibodies as Drugs or Devices: Practical and Regulatory Aspects. Drug Development and Industrial Pharmacy: Vol. 12, No. 1-2, pp. 107-227. doi: 10.3109/03639048609048022Keywords
This publication has 57 references indexed in Scilit:
- ImmunotoxinsTrends in Biotechnology, 1985
- Monoclonal antibodies — Approaching adolescence in diagnostic immunoassaysTrends in Biotechnology, 1985
- Bulk production of monoclonal antibodies in fermentersTrends in Biotechnology, 1985
- The Impact of New Cloning Techniques on the Diagnosis and Treatment of Infectious DiseasesNew England Journal of Medicine, 1984
- Elimination of Mycoplasma, Bacteria, and Fungi Contaminants of Hybridoma Cultures by Intraperitoneal Passage in the MouseHybridoma, 1984
- Advantages of rat monoclonal antibodiesImmunology Today, 1983
- Rapid Detection and Quantitation of Human Cytomegalovirus in Urine through DNA HybridizationNew England Journal of Medicine, 1983
- Hybridomas produce viruses as well as antibodiesImmunology Today, 1982
- Selective killing of mycoplasmas from contaminated mammalian cells in cell culturesNature, 1980
- Fusion of Two Immunoglobulin-producing Myeloma CellsNature, 1973